Pharmaceutical Primary Packaging - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512245867

Publication Date:

December 6, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Primary packaging is also known as sales packaging. Primary packaging is of great significance in pharmaceuticals. Because primary packaging is in the direct contact with the drug, so it is supposed to be inert and shouldn't cause any alteration in the chemical composition of the dosage.
The global market for Pharmaceutical Primary Packaging was estimated to be worth US$ 35150 million in 2023 and is forecast to a readjusted size of US$ 55360 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
The pharma primary packaging market is driven by the growing pharmaceutical industry and the increasing focus on drug safety and quality. Pharma primary packaging refers to the materials used to directly contain and protect pharmaceutical products, ensuring their integrity and efficacy throughout their shelf life. The rise in drug development and the need for reliable and compliant packaging solutions contribute to market growth as pharma companies seek packaging that maintains product stability and prevents contamination. Moreover, advancements in packaging technology, such as blister packs and tamper-evident seals, have improved patient safety and medication adherence. However, the market also faces challenges, including the need for sustainable and eco-friendly packaging solutions to address environmental concerns. Additionally, addressing the complexity of regulatory requirements and ensuring compatibility with various drug formulations can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and compliant pharma primary packaging, collaborate with pharmaceutical companies to meet specific packaging needs, and address the challenges to meet the increasing demand for safe and reliable packaging solutions in the pharmaceutical industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Primary Packaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Primary Packaging by region & country, by Type, and by Application.
The Pharmaceutical Primary Packaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Primary Packaging.
麻豆原创 Segmentation
By Company
Gerresheimer
Schott
Nipro
West-P
SGD
Shandong PG
Opmi
Rocco Bormioli
Ardagh
Amcor
ACG
Bilcare
Nipro
AptarGroup
Bemis Healthcare Packaging
Datwyler Packaging
Segment by Type:
Ampoules
Vials
Strip package
Blister Packaging
Syringe
Sachet Packaging
Other
Segment by Application
Vaccine
Medicine
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Primary Packaging manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmaceutical Primary Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmaceutical Primary Packaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Pharmaceutical Primary Packaging Product Introduction
1.2 Global Pharmaceutical Primary Packaging 麻豆原创 Size Forecast
1.3 Pharmaceutical Primary Packaging 麻豆原创 Trends & Drivers
1.3.1 Pharmaceutical Primary Packaging Industry Trends
1.3.2 Pharmaceutical Primary Packaging 麻豆原创 Drivers & Opportunity
1.3.3 Pharmaceutical Primary Packaging 麻豆原创 Challenges
1.3.4 Pharmaceutical Primary Packaging 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Primary Packaging Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Primary Packaging Revenue by Company (2019-2024)
2.3 Key Companies Pharmaceutical Primary Packaging Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmaceutical Primary Packaging Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Primary Packaging
2.6 Pharmaceutical Primary Packaging 麻豆原创 Competitive Analysis
2.6.1 Pharmaceutical Primary Packaging 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Primary Packaging Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Primary Packaging as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Ampoules
3.1.2 Vials
3.1.3 Strip package
3.1.4 Blister Packaging
3.1.5 Syringe
3.1.6 Sachet Packaging
3.1.7 Other
3.2 Global Pharmaceutical Primary Packaging Sales Value by Type
3.2.1 Global Pharmaceutical Primary Packaging Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Primary Packaging Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Primary Packaging Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Vaccine
4.1.2 Medicine
4.2 Global Pharmaceutical Primary Packaging Sales Value by Application
4.2.1 Global Pharmaceutical Primary Packaging Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Primary Packaging Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical Primary Packaging Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Primary Packaging Sales Value by Region
5.1.1 Global Pharmaceutical Primary Packaging Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Primary Packaging Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Primary Packaging Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Primary Packaging Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pharmaceutical Primary Packaging Sales Value, 2019-2030
5.2.2 North America Pharmaceutical Primary Packaging Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pharmaceutical Primary Packaging Sales Value, 2019-2030
5.3.2 Europe Pharmaceutical Primary Packaging Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical Primary Packaging Sales Value, 2019-2030
5.4.2 Asia Pacific Pharmaceutical Primary Packaging Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pharmaceutical Primary Packaging Sales Value, 2019-2030
5.5.2 South America Pharmaceutical Primary Packaging Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical Primary Packaging Sales Value, 2019-2030
5.6.2 Middle East & Africa Pharmaceutical Primary Packaging Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Primary Packaging Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Primary Packaging Sales Value
6.3 United States
6.3.1 United States Pharmaceutical Primary Packaging Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Primary Packaging Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Primary Packaging Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Primary Packaging Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Primary Packaging Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Primary Packaging Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Primary Packaging Sales Value, 2019-2030
6.5.2 China Pharmaceutical Primary Packaging Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Primary Packaging Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Primary Packaging Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Primary Packaging Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Primary Packaging Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Primary Packaging Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Primary Packaging Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Primary Packaging Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Primary Packaging Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Primary Packaging Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Primary Packaging Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Primary Packaging Sales Value, 2019-2030
6.9.2 India Pharmaceutical Primary Packaging Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Primary Packaging Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gerresheimer
7.1.1 Gerresheimer Profile
7.1.2 Gerresheimer Main Business
7.1.3 Gerresheimer Pharmaceutical Primary Packaging Products, Services and Solutions
7.1.4 Gerresheimer Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.1.5 Gerresheimer Recent Developments
7.2 Schott
7.2.1 Schott Profile
7.2.2 Schott Main Business
7.2.3 Schott Pharmaceutical Primary Packaging Products, Services and Solutions
7.2.4 Schott Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.2.5 Schott Recent Developments
7.3 Nipro
7.3.1 Nipro Profile
7.3.2 Nipro Main Business
7.3.3 Nipro Pharmaceutical Primary Packaging Products, Services and Solutions
7.3.4 Nipro Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.3.5 West-P Recent Developments
7.4 West-P
7.4.1 West-P Profile
7.4.2 West-P Main Business
7.4.3 West-P Pharmaceutical Primary Packaging Products, Services and Solutions
7.4.4 West-P Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.4.5 West-P Recent Developments
7.5 SGD
7.5.1 SGD Profile
7.5.2 SGD Main Business
7.5.3 SGD Pharmaceutical Primary Packaging Products, Services and Solutions
7.5.4 SGD Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.5.5 SGD Recent Developments
7.6 Shandong PG
7.6.1 Shandong PG Profile
7.6.2 Shandong PG Main Business
7.6.3 Shandong PG Pharmaceutical Primary Packaging Products, Services and Solutions
7.6.4 Shandong PG Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.6.5 Shandong PG Recent Developments
7.7 Opmi
7.7.1 Opmi Profile
7.7.2 Opmi Main Business
7.7.3 Opmi Pharmaceutical Primary Packaging Products, Services and Solutions
7.7.4 Opmi Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.7.5 Opmi Recent Developments
7.8 Rocco Bormioli
7.8.1 Rocco Bormioli Profile
7.8.2 Rocco Bormioli Main Business
7.8.3 Rocco Bormioli Pharmaceutical Primary Packaging Products, Services and Solutions
7.8.4 Rocco Bormioli Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.8.5 Rocco Bormioli Recent Developments
7.9 Ardagh
7.9.1 Ardagh Profile
7.9.2 Ardagh Main Business
7.9.3 Ardagh Pharmaceutical Primary Packaging Products, Services and Solutions
7.9.4 Ardagh Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.9.5 Ardagh Recent Developments
7.10 Amcor
7.10.1 Amcor Profile
7.10.2 Amcor Main Business
7.10.3 Amcor Pharmaceutical Primary Packaging Products, Services and Solutions
7.10.4 Amcor Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.10.5 Amcor Recent Developments
7.11 ACG
7.11.1 ACG Profile
7.11.2 ACG Main Business
7.11.3 ACG Pharmaceutical Primary Packaging Products, Services and Solutions
7.11.4 ACG Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.11.5 ACG Recent Developments
7.12 Bilcare
7.12.1 Bilcare Profile
7.12.2 Bilcare Main Business
7.12.3 Bilcare Pharmaceutical Primary Packaging Products, Services and Solutions
7.12.4 Bilcare Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.12.5 Bilcare Recent Developments
7.13 Nipro
7.13.1 Nipro Profile
7.13.2 Nipro Main Business
7.13.3 Nipro Pharmaceutical Primary Packaging Products, Services and Solutions
7.13.4 Nipro Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.13.5 Nipro Recent Developments
7.14 AptarGroup
7.14.1 AptarGroup Profile
7.14.2 AptarGroup Main Business
7.14.3 AptarGroup Pharmaceutical Primary Packaging Products, Services and Solutions
7.14.4 AptarGroup Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.14.5 AptarGroup Recent Developments
7.15 Bemis Healthcare Packaging
7.15.1 Bemis Healthcare Packaging Profile
7.15.2 Bemis Healthcare Packaging Main Business
7.15.3 Bemis Healthcare Packaging Pharmaceutical Primary Packaging Products, Services and Solutions
7.15.4 Bemis Healthcare Packaging Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.15.5 Bemis Healthcare Packaging Recent Developments
7.16 Datwyler Packaging
7.16.1 Datwyler Packaging Profile
7.16.2 Datwyler Packaging Main Business
7.16.3 Datwyler Packaging Pharmaceutical Primary Packaging Products, Services and Solutions
7.16.4 Datwyler Packaging Pharmaceutical Primary Packaging Revenue (US$ Million) & (2019-2024)
7.16.5 Datwyler Packaging Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Primary Packaging Industrial Chain
8.2 Pharmaceutical Primary Packaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Primary Packaging Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Primary Packaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Gerresheimer
Schott
Nipro
West-P
SGD
Shandong PG
Opmi
Rocco Bormioli
Ardagh
Amcor
ACG
Bilcare
Nipro
AptarGroup
Bemis Healthcare Packaging
Datwyler Packaging

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.